All PlansAdministrativeMedium impact
06.02.47f, Noninvasive Prenatal Screening for Fetal Aneuploidies Using Cell-Free Fetal DNA (Independence Administrators)
Independence Blue Cross·Medical Policy
We identified it
Jun 25, 2026
Summary
Failed to analyze policy change